Market Research Logo

Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review

Trillium Therapeutics Inc (TR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, is a clinical stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company’s lead program, TTI-621, a SIRPaFc fusion protein is being developed for hematological malignancies. Its second SIRPaFc fusion protein, TTI-622, is primarily being developed for combination therapy. Trillium has developed a proprietary medicinal chemistry platform that is used for the creation of new chemical entities with improved pharmacological properties from validated drugs and drug candidates. The company utilizing this platform is also developing bromodomain inhibitor and epidermal growth factor receptor antagonist. Trillium is headquartered in Mississauga, Ontario, Canada.

Trillium Therapeutics Inc Key Recent Developments

May 12,2017: Trillium Reports First Quarter 2017 Financial and Operating Results
Mar 10,2017: Trillium Therapeutics Reports Annual 2016 Financial and Operating Results
Nov 10,2016: Trillium Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 03,2016: Trillium Therapeutics Announces Investor And Scientific Presentation Schedule For Remainder Of 2016
Aug 12,2016: Trillium Reports Second Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Trillium Therapeutics Inc - Key Facts 5
Trillium Therapeutics Inc - Key Employees 6
Trillium Therapeutics Inc - Key Employee Biographies 7
Trillium Therapeutics Inc - Major Products and Services 8
Trillium Therapeutics Inc - History 9
Trillium Therapeutics Inc - Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Trillium Therapeutics Inc - Business Description 11
Trillium Therapeutics Inc - Corporate Strategy 12
Trillium Therapeutics Inc - SWOT Analysis 13
SWOT Analysis - Overview 13
Trillium Therapeutics Inc - Strengths 13
Trillium Therapeutics Inc - Weaknesses 14
Trillium Therapeutics Inc - Opportunities 15
Trillium Therapeutics Inc - Threats 16
Trillium Therapeutics Inc - Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios - Capital Market Ratios 18
Financial Ratios - Annual Ratios 19
Performance Chart 21
Financial Performance 21
Financial Ratios - Interim Ratios 22
Financial Ratios - Ratio Charts 23
Section 4 – Company’s Lifesciences Financial Deals and Alliances 24
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Trillium Therapeutics Inc, Recent Deals Summary 26
Section 5 – Company’s Recent Developments 27
May 12, 2017: Trillium Reports First Quarter 2017 Financial and Operating Results 27
Mar 10, 2017: Trillium Therapeutics Reports Annual 2016 Financial and Operating Results 28
Nov 10, 2016: Trillium Reports Third Quarter 2016 Financial Results and Provides Corporate Update 29
Nov 03, 2016: Trillium Therapeutics Announces Investor And Scientific Presentation Schedule For Remainder Of 2016 30
Aug 12, 2016: Trillium Reports Second Quarter 2016 Financial Results 32
May 13, 2016: Trillium Reports First Quarter 2016 Financial Results 33
Mar 09, 2016: Trillium Reports 2015 Financial and Operating Results 34
Section 6 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Trillium Therapeutics Inc, Key Facts 5
Trillium Therapeutics Inc, Key Employees 6
Trillium Therapeutics Inc, Key Employee Biographies 7
Trillium Therapeutics Inc, Major Products and Services 8
Trillium Therapeutics Inc, History 9
Trillium Therapeutics Inc, Subsidiaries 10
Trillium Therapeutics Inc, Key Competitors 17
Trillium Therapeutics Inc, Ratios based on current share price 18
Trillium Therapeutics Inc, Annual Ratios 19
Trillium Therapeutics Inc, Annual Ratios (Cont...1) 20
Trillium Therapeutics Inc, Interim Ratios 22
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Trillium Therapeutics Inc, Recent Deals Summary 26
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38
List of Figuress
Trillium Therapeutics Inc, Performance Chart (2012 - 2016)
Trillium Therapeutics Inc, Ratio Charts
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Trillium Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report